JO
AGN

John Overdeck’s Allergan plc AGN Stock Holding History

John Overdeck’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-281,381
Closed -$49.8M – 3772
2020
Q1 		$49.8M Sell
281,381
-375,056
-57% -$70.6M 0.41% 36
2019
Q4 		$125M Buy
656,437
+515,127
+365% +$92.9M 0.38% 49
2019
Q3 		$23.8M Buy
+141,310
New +$23M 0.08% 307
2018
Q3 		– Sell
-2,102
Closed -$386K – 3787
2018
Q2 		$350K Buy
+2,102
New +$337K ﹤0.01% 2859
2018
Q1 		– Sell
-444,832
Closed -$74.6M – 3706
2017
Q4 		$72.8M Buy
+444,832
New +$79.8M 0.24% 108
2016
Q3 		– Sell
-65,302
Closed -$15.1M – 3486
2016
Q2 		$15.1M Sell
65,302
-536,603
-89% -$124M 0.06% 358
2016
Q1 		$161M Buy
601,905
+80,817
+16% +$23.1M 0.77% 9
2015
Q4 		$163M Buy
521,088
+514,188
+7,452% +$153M 0.78% 8
2015
Q3 		$1.88M Buy
6,900
+2,700
+64% +$829K 0.01% 876
2015
Q2 		$1.27M Buy
+4,200
New +$1.25M 0.01% 1494
2014
Q4 		– Sell
-373,189
Closed -$90M – 2457
2014
Q3 		$90M Sell
373,189
-362,609
-49% -$81.1M 0.4% 60
2014
Q2 		$164M Buy
735,798
+287,568
+64% +$59.5M 0.74% 3
2014
Q1 		$92.3M Buy
448,230
+428,700
+2,195% +$84.9M 0.49% 30
2013
Q4 		$3.28M Sell
19,530
-176,904
-90% -$27.7M 0.02% 781
2013
Q3 		$28.3M Sell
196,434
-336,327
-63% -$44.8M 0.18% 146
2013
Q2 		$67.2M Buy
+532,761
New +$60.3M 0.47% 37

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

John Overdeck's AGN Position: Q2 2020 in Review

John Overdeck sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 281,381 shares — an estimated $49.8M sold.

John Overdeck first reported a position in AGN in Q2 2013 and held it in 16 quarters. The position peaked at $164M in Q2 2014. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • John Overdeck reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • John Overdeck sold 281,381 Allergan plc shares in Q2 2020, an estimated $49.8M.
  • John Overdeck first reported a position in Allergan plc in Q2 2013 and held it in 16 quarters.
  • John Overdeck's Allergan plc position peaked at $164M in Q2 2014.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Two Sigma Investments's 13F filing for Q2 2020, filed 14 Aug 2020.